Genesis Sibutramine Tablets 100 tabs (20 mg/tab)

Sibutramine

Sibutramine tablets are designed to assist individuals with obesity in achieving weight loss when combined with a low-calorie diet. Most users experience significant weight reduction within the first six months of using Sibutramine tablets along with diet and exercise.

Initially marketed by Abbott Laboratories as Meridia® in the USA and Reductil® in Europe, Meridia and Reductil are the brand names associated with this weight loss medication. Generally, pharmaceutical products are initially sold under a patent that limits its distribution to the developer. Once the patent expires, generic drugs, including generic Sibutramine, enter the market at lower prices while maintaining the same effectiveness.

Generic formulations must have the same active ingredients and are considered equivalent in terms of dose, strength, administration route, safety, efficacy, and intended use. Typically, generic products are released only after the original patent period has concluded, promoting competition that often results in reduced costs for both the brand name and its generic counterparts.

Dosage

10-20 mg/day – variation